Maximum quantity allowed is 999
请选择数量
CAS RN: 51333-22-3 | 產品號碼: B3909
產品號碼 | B3909 |
純度/分析方法 ![]() |
>98.0%(HPLC) |
分子式 / 分子量 | C__2__5H__3__4O__6 = 430.54 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 ![]() |
1G-Glass Bottle with Plastic Insert (閲覽圖片), 200MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 51333-22-3 |
Reaxys-RN | 3633996 |
PubChem Substance ID | 160871371 |
Merck Index(14) | 1468 |
MDL編號 | MFCD00083259 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 % (total of isomers) |
Elemental analysis(Carbon) | 68.00 to 71.00 % |
Specific rotation [a]20/D | +100 to +110 deg(C=0.28、CH2Cl2) |
性質
比旋光 [α]D | 105° (C=0.28,CH2Cl2) |
水溶性 | Insoluble |
溶解性(可溶於) | Chloroform, Methanol |
溶解性(微溶於) | Acetone, Ethanol |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H315 : Causes skin irritation. |
防範說明 | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of water. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
相關法規
RTECS # | TU3723000 |
運輸資料
HS編碼* | 2937.29-000 |
Application
Budesonide: A Potent Glucocorticoid Receptor Antagonist
Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity.1-6) Budesonide has a strong affinity for glucocorticoid receptor, and it is reported that budesonide has approximately 8.5-fold, 15-fold, and 195-fold greater than those of dexamethasone [D1961], prednisolone [P0637], and hydrocortisone [H0533], respectively.6) Budesonide is mainly metabolized by CYP3A4.6) (The product is for research purpose only.)
References
- 1)Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids(a review)
- 2)Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis(a review)
- 3)Budesonide: A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease(a review)
- 4)Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease(a review)
- 5)Treatment of inflammatory bowel disease: a review of medical therapy(a review)
- 6)Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis (a review)
考研文獻
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。